alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                EXHIBIT  11

                   GOVERNMENT TECHNOLOGY SERVICES, INC.
                     COMPUTATION OF EARNINGS PER SHARE
                 (In thousands, except per share amounts)


<TABLE>
<CAPTION>
                                                                    THREE               NINE
                                                                MONTHS ENDED        MONTHS ENDED
                                                                SEPTEMBER 30,       SEPTEMBER 30,  
                                                             ------------------  ------------------
                                                               1998      1997      1998      1997  
                                                             --------  --------  --------   --------
<S>                                                          <C>       <C>       <C>        <C>
Net income (loss) . . . . . . . . . . . . . . . . . . . . .  $  3,960  $  1,891  $    618   $(4,500)
                                                             --------  --------  --------   --------

Weighted average shares of common stock outstanding . . . .     9,788     6,740     8,333     6,730

Weighted average effect of common share equivalents . . . .        61       308       229       N/A
                                                             --------  --------  --------   --------

Weighted average shares outstanding . . . . . . . . . . . .     9,849     7,048     8,562     6,730
                                                             --------  --------  --------   --------

Net income (loss) per common share and common share
  equivalent. . . . . . . . . . . . . . . . . . . . . . . .  $   0.40  $   0.27  $   0.07   $ (0.67)
                                                             ========  ========  ========   ========
</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               JUN-30-1996
<CASH>                                       7,289,631
<SECURITIES>                                         0
<RECEIVABLES>                                   65,259
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             7,630,120
<PP&E>                                       2,732,526
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              19,071,106
<CURRENT-LIABILITIES>                        2,636,403
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        16,153
<OTHER-SE>                                  16,056,550
<TOTAL-LIABILITY-AND-EQUITY>                19,071,106
<SALES>                                        112,921
<TOTAL-REVENUES>                               112,921
<CGS>                                          373,203
<TOTAL-COSTS>                                  373,203
<OTHER-EXPENSES>                             1,386,162
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              77,937
<INCOME-PRETAX>                             (1,710,982)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,710,982)
<EPS-PRIMARY>                                     (.13)
<EPS-DILUTED>                                        0


        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 6
 

<CIK>     0000744822


<NAME>      Fidelity Investment Trust


<SERIES>

        <NUMBER>        191


        <NAME>      Fidelity Germany Fund


<MULTIPLIER>    1,000


       

<S>

<C>

<PERIOD-TYPE>

6-MOS


<FISCAL-YEAR-END>

OCT-31-1998


<PERIOD-END>

APR-30-1998


<INVESTMENTS-AT-COST>

13,344


<INVESTMENTS-AT-VALUE>

17,553


<RECEIVABLES>

108


<ASSETS-OTHER>

0


<OTHER-ITEMS-ASSETS>

0


<TOTAL-ASSETS>

17,661


<PAYABLE-FOR-SECURITIES>

0


<SENIOR-LONG-TERM-DEBT>

0


<OTHER-ITEMS-LIABILITIES>

55


<TOTAL-LIABILITIES>

55


<SENIOR-EQUITY>

0


<PAID-IN-CAPITAL-COMMON>

12,994


<SHARES-COMMON-STOCK>

1,094


<SHARES-COMMON-PRIOR>

962


<ACCUMULATED-NII-CURRENT>

(99)


<OVERDISTRIBUTION-NII>

0


<ACCUMULATED-NET-GAINS>

503


<OVERDISTRIBUTION-GAINS>

0


<ACCUM-APPREC-OR-DEPREC>

4,208


<NET-ASSETS>

17,606


<DIVIDEND-INCOME>

20


<INTEREST-INCOME>

20


<OTHER-INCOME>

(2)


<EXPENSES-NET>

137


<NET-INVESTMENT-INCOME>

(99)


<REALIZED-GAINS-CURRENT>

560


<APPREC-INCREASE-CURRENT>

3,590


<NET-CHANGE-FROM-OPS>

4,051


<EQUALIZATION>

0


<DISTRIBUTIONS-OF-INCOME>

0


<DISTRIBUTIONS-OF-GAINS>

1,176


<DISTRIBUTIONS-OTHER>

0


<NUMBER-OF-SHARES-SOLD>

302


<NUMBER-OF-SHARES-REDEEMED>

262


<SHARES-REINVESTED>

93


<NET-CHANGE-IN-ASSETS>

4,874


<ACCUMULATED-NII-PRIOR>

0


<ACCUMULATED-GAINS-PRIOR>

1,687


<OVERDISTRIB-NII-PRIOR>

0


<OVERDIST-NET-GAINS-PRIOR>

0


<GROSS-ADVISORY-FEES>

52


<INTEREST-EXPENSE>

0


<GROSS-EXPENSE>

160


<AVERAGE-NET-ASSETS>

13,983


<PER-SHARE-NAV-BEGIN>

13.240


<PER-SHARE-NII>

(.100)


<PER-SHARE-GAIN-APPREC>

4.200


<PER-SHARE-DIVIDEND>

0


<PER-SHARE-DISTRIBUTIONS>

1.250


<RETURNS-OF-CAPITAL>

0


<PER-SHARE-NAV-END>

16.090


<EXPENSE-RATIO>

200


<AVG-DEBT-OUTSTANDING>

0


<AVG-DEBT-PER-SHARE>

0



        



</TABLE>
Exhibit 31.1

**Rule 13a-14(a) CERTIFICATIONS**

I, P. Douglas Richard, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Community Financial Corporation (the "Registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects
the consolidated financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;

b) evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report; and

c) disclosed in this report any changes in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal
quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation, to the Registrant's auditors and the audit committee of
Registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the Registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over
financial reporting.

Date: November 14, 2005

---
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

__________________

NO. 09-22-00077-CR

__________________

IN RE FABBIAN DONTA SCOTT

__________________________________________________________________

Original Proceeding

Criminal District Court of Jefferson County, Texas

Trial Cause Nos. 21-36748 & 21-36749

__________________________________________________________________

MEMORANDUM OPINION

In a petition for a writ of mandamus, Fabbian Donta Scott asks this Court to 

compel the trial court to hold an evidentiary hearing and rule on a motion to quash 

the indictments as a matter of law. Scott complains that the trial court failed to “give 

an attentive ear[]” before denying the motion to quash on January 31, 2022. Also, 

he complains of alleged misconduct of the prosecutor.

The record before this Court fails to establish that Scott seeks to compel a 

ministerial act, not involving a discretionary or judicial decision, for which he lacks 

an adequate remedy at law. See State ex rel. Young v. Sixth Judicial Dist. Court of 
2

Appeals at Texarkana, 236 S.W.3d 207, 210 (Tex. Crim. App. 2007) (orig. 

proceeding). We deny the petition for a writ of mandamus.

PETITION DENIED.

PER CURIAM

Submitted on March 22, 2022

Opinion Delivered March 23, 2022

Do Not Publish

Before Golemon, C.J., Kreger and Johnson, JJ.
----

DECISION OF THE EUROPEAN PARLIAMENT

of 21 April 2004

concerning discharge in respect of the implementation of the general budget of the European Union for the 2002 financial year — Section IV — Court of Justice

(2004/724/EC)

THE EUROPEAN PARLIAMENT,

having regard to the revenue and expenditure account and balance sheet for the 2002 financial year (I5-0034/2003 — C5-0088/2004),

having regard to the Annual Report of the European Court of Auditors for the 2002 financial year, together with the replies of the institutions (C5-0583/2003) (1),

having regard to the statement of assurance by the European Court of Auditors, pursuant to Article 248 of the EC Treaty, as to the reliability of the accounts and the legality and regularity of the underlying transactions (C5-0583/2003),

having regard to the Council's recommendation of 9 March 2003 (C5-0145/2004),

having regard to Article 272(10) and Article 275 of the EC Treaty,

having regard to Article 22(2) and (3) of the Financial Regulation of 21 December 1977 (2) and Article 50 of the Financial Regulation of 25 June 2002 (3),

having regard to Rule 93a of and Annex V to its Rules of Procedure,

having regard to the report of the Committee on Budgetary Control (A5-0228/2004),

The Secretary-General

Julian PRIESTLEY

The President

Pat COX

----

(1)OJ C 286, 28.11.2003, p. 1.

(2)OJ L 356, 31.12.1977, p. 1.

(3)OJ L 248, 16.9.2002, p. 1.

----

RESOLUTION

of the European Parliament containing the comments accompanying the decision concerning discharge in respect of the implementation of the general budget of the European Union for the 2002 financial year — Section IV — Court of Justice

THE EUROPEAN PARLIAMENT,

having regard to the revenue and expenditure account and balance sheet for the 2002 financial year (I5-0034/2003 — C5-0088/2004),

having regard to the Annual Report of the European Court of Auditors for the 2002 financial year, together with the replies of the institutions (C5-0583/2003) (1),

having regard to the statement of assurance by the European Court of Auditors, pursuant to Article 248 of the EC Treaty, as to the reliability of the accounts and the legality and regularity of the underlying transactions (C5-0583/2003),

having regard to the Council's recommendation of 9 March 2004 (C5-0145/2004),

having regard to Article 272(10) and Article 275 of the EC Treaty,

having regard to Article 22(2) and (3) of the Financial Regulation of 21 December 1977 (2) and Article 50 of the Financial Regulation of 25 June 2002 (3),

having regard to Rule 93a of and Annex V to its Rules of Procedure,

having regard to the report of the Committee on Budgetary Control (A5-0228/2004),

Non-official use of official cars

Increases in remuneration as a result of weightings

----

(1)OJ C 286, 28.11.2003, p. 1.

(2)OJ L 356, 31.12.1977, p. 1.

(3)OJ L 248, 16.9.2002, p. 1.

(4)OJ C 109, 14.4.2000, p. 1.

(5)  Letter of 6 June 2003 to the chairman of the Committee on Budgetary Control.

(6)  Resolution of 8 April 2003, paragraph 6 (OJ L 148, 16.6.2003, p. 46).

----
<TABLE> <S> <C>

<ARTICLE>	6

<CIK>	0000744822

<NAME>	Fidelity Investment Trust

<SERIES>

	<NUMBER>	191

	<NAME>	Fidelity Germany Fund

<MULTIPLIER>	1,000



<S>

<C>

<PERIOD-TYPE>
year
<FISCAL-YEAR-END>
oct-31-1999
<PERIOD-END>
oct-31-1999
<INVESTMENTS-AT-COST>
18,968
<INVESTMENTS-AT-VALUE>
22,812
<RECEIVABLES>
1,713
<ASSETS-OTHER>
6
<OTHER-ITEMS-ASSETS>
0
<TOTAL-ASSETS>
24,531
<PAYABLE-FOR-SECURITIES>
1,328
<SENIOR-LONG-TERM-DEBT>
0
<OTHER-ITEMS-LIABILITIES>
244
<TOTAL-LIABILITIES>
1,572
<SENIOR-EQUITY>
0
<PAID-IN-CAPITAL-COMMON>
24,553
<SHARES-COMMON-STOCK>
1,532
<SHARES-COMMON-PRIOR>
2,352
<ACCUMULATED-NII-CURRENT>
0
<OVERDISTRIBUTION-NII>
0
<ACCUMULATED-NET-GAINS>
(5,438)
<OVERDISTRIBUTION-GAINS>
0
<ACCUM-APPREC-OR-DEPREC>
3,844
<NET-ASSETS>
22,959
<DIVIDEND-INCOME>
323
<INTEREST-INCOME>
32
<OTHER-INCOME>
0
<EXPENSES-NET>
440
<NET-INVESTMENT-INCOME>
(85)
<REALIZED-GAINS-CURRENT>
(2,185)
<APPREC-INCREASE-CURRENT>
2,398
<NET-CHANGE-FROM-OPS>
128
<EQUALIZATION>
0
<DISTRIBUTIONS-OF-INCOME>
0
<DISTRIBUTIONS-OF-GAINS>
0
<DISTRIBUTIONS-OTHER>
0
<NUMBER-OF-SHARES-SOLD>
1,168
<NUMBER-OF-SHARES-REDEEMED>
1,988
<SHARES-REINVESTED>
0
<NET-CHANGE-IN-ASSETS>
(11,836)
<ACCUMULATED-NII-PRIOR>
17
<ACCUMULATED-GAINS-PRIOR>
(3,259)
<OVERDISTRIB-NII-PRIOR>
0
<OVERDIST-NET-GAINS-PRIOR>
0
<GROSS-ADVISORY-FEES>
181
<INTEREST-EXPENSE>
0
<GROSS-EXPENSE>
468
<AVERAGE-NET-ASSETS>
24,592
<PER-SHARE-NAV-BEGIN>
14.790
<PER-SHARE-NII>
(.050)
<PER-SHARE-GAIN-APPREC>
 .190
<PER-SHARE-DIVIDEND>
0
<PER-SHARE-DISTRIBUTIONS>
0
<RETURNS-OF-CAPITAL>
0
<PER-SHARE-NAV-END>
14.980
<EXPENSE-RATIO>
190





</TABLE>
CERTIFICATION PURSUANT TO
                               18 U.S.C. ss.1350,
                                   PURSUANT TO
                            AS ADOPTED PURSUANT TO TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with  the  Annual  Report  of  Wells  Financial   Corp.(the
"Company") on Form 10-KSB for the period ending  December 31, 2002 as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  we,
Lonnie R. Trasamar,  President and Chief Executive  Officer,  and James D. Moll,
Treasurer (Principal Financial and Accounting Officer),  certify, pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:

     (1) The Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.


<TABLE>
<CAPTION>

<S>                                         <C>
/s/Lonnie R. Trasamar                           /s/James D. Moll
-------------------------------------           -------------------------------------------
Lonnie R. Trasamar                              James D. Moll
President and Chief Executive Officer           Treasurer
(Principal Executive Officer)                   (Principal Financial and Accounting Officer

Date:   March 25, 2003                          Date:   March 25, 2003


</TABLE>
##### 








---



##### 



Third Amendment Borrower Bank of America Wells Fargo Lenders
 BACKGROUND
 Encore Limited Credit Agreement
 Merger Agreement Merger
     AMENDMENTS
 Borrower
 1




---



##### 



Borrower
 Change of Control
 Change of Control
 EWC GP EWC LP
 Parent Parent
  Purpose and Use of Funds
  Corporate Existence
 2




---



##### 



Corporate Power and Authority; Validity
  No Conflicting Agreements; No Consents
  Aviation Schedule 6.7
    Compliance Certificate
 3




---



##### 



Annual Financial Statements
  Interim Financial Statements
  Notification Regarding Default
 4




---



##### 



(provided,
  Limitation on Indebtedness provided
  Dividends, Distributions, Redemptions
 5




---



##### 



provided, however provided,
 ASSUMPTION OF RIGHTS AND LIABILITIES
 CONSENT
 REPRESENTATIONS AND WARRANTIES TRUE; NO EVENT OF DEFAULT
   Replacement Notes
  6




---



##### 



CONDITIONS TO EFFECTIVENESS
        LEGAL OPINION Section 4
 7




---



##### 



REFERENCE TO THE CREDIT AGREEMENT
   COSTS, EXPENSES AND TAXES
 GUARANTORS ACKNOWLEDGMENT
 EXECUTION IN COUNTERPARTS
 GOVERNING LAW; BINDING EFFECT
 HEADINGS
 ENTIRE AGREEMENT
 8




---



##### 



9




---



##### 



BORROWER:
ENCORE WIRE CORPORATIONBy:
    /s/ Frank J. BilbanName:
    Frank J. BilbanTitle:
    Vice President & Chief Financial
Officer 1




---



##### 



ADMINISTRATIVE AGENT:
BANK OF AMERICA, N.A.By:
    /s/ Suzanne M. PaulName:
    Suzanne M. PaulTitle:
    Vice PresidentBANK OF AMERICA, N.A., as a LenderBy:
    /s/ Steven A. MackenzieName:
    Steven A. MackenzieTitle:
    Senior Vice President 2




---



##### 



WELLS FARGO BANK, NATIONAL ASSOCIATION, as a LenderBy:
    /s/ Jay W. DennyName:
    Jay W. DennyTitle:
    Senior Vice President 3




---



##### 



ACKNOWLEDGED AND AGREED:EWC AVIATION CORP.By:
    /s/ Frank J. BilbanName:
    Frank J. BilbanTitle:
    Vice President & Chief Financial Officer  4
Exhibit
10.15 


 


ASSIGNMENT
AND ASSUMPTION AGREEMENT


 


THIS
ASSIGNMENT AND ASSUMPTION AGREEMENT (“Assignment
and Assumption Agreement”) is effective as of September 15 2015, by and between by and between Fortress Biotech.,
Inc., a Delaware corporation (“Fortress”)
and Checkpoint Therapeutics, Inc., a Delaware corporation (“Checkpoint”).


 


RECITALS


 


WHEREAS,
Fortress and NeuPharma (“NeuPharma”)
are parties to that certain Research Agreement (the “NeuPharma
Agreement”);


 


WHEREAS,
pursuant to the NeuPharma Agreement, Fortress may assign the NeuPharma Agreement to an Affiliate (as defined in the NeuPharma Agreement)
of Fortress without NeuPharma’s prior written consent; and


 


WHEREAS,
Checkpoint is an Affiliate of Fortress; and


 


WHEREAS,
Fortress wishes to assign the NeuPharma Agreement to Checkpoint and, in connection therewith, Checkpoint has agreed to accept such
assignment and assume the obligations thereunder.


 


AGREEMENTS


 


NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is hereby agreed
that:


 


1.          Assignment.
Fortress hereby sells, assigns, conveys, transfers and delivers to Checkpoint all of Fortress’s right, title
and interest in and to the NeuPharma Agreement.


 


2.          Assumption.
Checkpoint hereby accepts the foregoing assignment, and in connection therewith, Checkpoint hereby agrees to assume
all liabilities arising thereunder from and after the Effective Date.


 


4.          Effective
Time. The effective time of this Assignment and Assumption Agreement is 11:59 p.m. EST on the date hereof.


 


5.          Counterparts;
Electronic Delivery. This Assignment and Assumption Agreement may be executed in any number of counterparts with
the same effect as if each of the parties hereto had signed the same document. All counterparts shall be construed together and
shall constitute one Assignment and Assumption Agreement. This Assignment and Assumption Agreement, to the extent signed and delivered
by means of a facsimile machine or via e-mail, shall be treated in all manner and respects as an original agreement or instrument
and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person.


 




     


     


    

  


IN
WITNESS WHEREOF, the parties have executed this Assignment and Assumption Agreement as of the date first above written.


 


	FORTRESS
    BIOTECH, INC.	 
	 	 	 
	By:	/s/
    Lindsay Rosenwald	 
	 	 	 
	Name:	Lindsay Rosenwald	 
	 	 	 
	Title:	CEO	 
	 	 	 
	CHECKPOINT THERAPEUTICS, INC.	 
	 	 	 
	By:	/s/
    Michael Weiss	 
	 	 	 
	Name:	Michael
    Weiss	 
	 	 	 
	Title:	Interim President
    and CEO	 


 


[Signature
Page to Assignment and Assumption Agreement]
mbcc-ex1015_38.htm



Exhibit 10.15

 

AMENDMENT TO SHARED SERVICES AGREEMENT

 

This Amendment dated as of January 1, 2016 (“Amendment Effective Date”) by and between Nexstar Broadcasting, Inc. (“Nexstar”) and Mission Broadcasting, Inc. (“Mission”) is made to that certain Shared Services Agreement dated as of March 1, 2013 (“Agreement”).

 

WHEREAS, Mission is the licensee of television broadcast station WVNY, Burlington, Vermont;

 

WHEREAS, Nexstar is the licensee of television broadcasting station WFFF-TV, Burlington, Vermont; 

 

WHEREAS, Mission and Nexstar have entered into the Agreement for their mutual benefit;

 

NOW THEREFORE, for and in consideration of the foregoing, Nexstar and Mission hereby amend the Agreement as follows:

 

1. Paragraph 4(g) of the Agreement is deleted in its entirety and the following is substituted in its place: “4(g) Services Fee. In consideration for the services to be provided to the Stations by Nexstar personnel as described in Sections 4(a) through 4(f), Mission will pay Nexstar the fee (“Services Fee”) described in Section 4(g).

 

(i)Base Amount. Subject to the remaining provisions of this Section 4(g), the base amount of the Services Fee will be $125,000 per month.

 

(ii) Payment Terms. The Services Fee will be payable monthly, in arrears, from and after the month during which this Agreement is executed, and will be prorated on a daily basis for the first and last months during which the sharing arrangements described in Sections 4(a) through 4(f) are in effect.” 

 

2.These revised payment terms are effective as of the Amendment Effective Date.

 

3. As so amended, all sections and provisions of the Agreement are hereby ratified in full. 

 

IN WITNESS WHEREOF, the parties have executed this amendment as of the Amendment Effective Date above.

 


			
	
NEXSTAR BROADCASTING, INC.

 
	
 
	
MISSION BROADCASTING, INC.

	
By: /s/ Thomas E. Carter
	
 
	
By: /s/ Dennis Thatcher

	
 

Name: Thomas E. Carter
	
 
	
 

Name: Dennis Thatcher

	
 

Title: EVP & Chief Financial Officer
	
 
	
 

Title: President
Daniel TAYLOR, petitioner, v. Walter BERRY, Warden.

No. 16-6056.

Supreme Court of the United States

Nov. 28, 2016.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.